{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:28:57Z","timestamp":1793330937049,"version":"4.5.0"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T00:00:00Z","timestamp":1683158400000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Travel Medicine and Infectious Disease"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.tmaid.2023.102585","type":"journal-article","created":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T22:16:59Z","timestamp":1683238619000},"page":"102585","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["\u201cOne-shot\u201d combined therapy with oral ivermectin and local benzyl benzoate: is the current best therapeutic option in the era of permethrin resistant scabies?"],"prefix":"10.1016","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9157-5189","authenticated-orcid":false,"given":"Andrea","family":"Bassi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7798-4368","authenticated-orcid":false,"given":"Vincenzo","family":"Piccolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3780-5721","authenticated-orcid":false,"given":"Carlo","family":"Mazzatenta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.tmaid.2023.102585_bib1","first-page":"33","article-title":"Scabies: a neglected global disease","volume":"16","author":"Leung","year":"2020","journal-title":"Curr Pediatr Rev"},{"key":"10.1016\/j.tmaid.2023.102585_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2020.101552","article-title":"Persistent, highly pruritic nodular skin lesions in a traveler returning from Guyana","volume":"33","author":"Becker","year":"2020","journal-title":"Trav Med Infect Dis"},{"issue":"9","key":"10.1016\/j.tmaid.2023.102585_bib3","doi-asserted-by":"crossref","first-page":"e607","DOI":"10.1111\/jdv.17339","article-title":"Is Scabies becoming less sensitive to permethrin therapy?","volume":"35","author":"Mazzatenta","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"9","key":"10.1016\/j.tmaid.2023.102585_bib4","doi-asserted-by":"crossref","first-page":"e712","DOI":"10.1111\/jdv.18181","article-title":"European scabies challenge: what about permethrin-resistant mites?","volume":"36","author":"Mayer","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.tmaid.2023.102585_bib5","first-page":"S0001","article-title":"Resistance to permethrin in scabies treatment: does it really exist?","volume":"22","author":"Velasco-Amador","year":"2022","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.tmaid.2023.102585_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2022.102461","article-title":"Diagnosis and management of pediatric scabies: results from a survey on 317 Italian dermatologists","volume":"50","author":"Bassi","year":"2022","journal-title":"Trav Med Infect Dis"},{"key":"10.1016\/j.tmaid.2023.102585_bib7","article-title":"A resistant parasitic flare-up amid children in Italy: comment on \"Diagnosis and management of pediatric scabies: results from a survey on 317 Italian dermatologists","volume":"18","author":"Herzum","year":"2023","journal-title":"Trav Med Infect Dis"},{"issue":"7","key":"10.1016\/j.tmaid.2023.102585_bib8","doi-asserted-by":"crossref","first-page":"e557","DOI":"10.1111\/jdv.18026","article-title":"Topical ivermectin: an off-label alternative to treat neonatal Scabies in the era of permethrin resistance","volume":"36","author":"Bassi","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"10.1016\/j.tmaid.2023.102585_bib9","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.14351","article-title":"European guideline for the management of scabies","volume":"31","author":"Salavastru","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"9","key":"10.1016\/j.tmaid.2023.102585_bib10","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/1346-8138.13896","article-title":"Guideline for the diagnosis and treatment of scabies in Japan (third edition): executive committee of guideline for the diagnosis and treatment of scabies","volume":"44","year":"2017","journal-title":"J Dermatol"},{"key":"10.1016\/j.tmaid.2023.102585_bib11","first-page":"1","article-title":"Loss of efficacy of topical 5% permethrin for treating scabies: an Austrian single-center study","volume":"4","author":"Meyersburg","year":"2020","journal-title":"J Dermatol Treat"},{"issue":"1","key":"10.1016\/j.tmaid.2023.102585_bib12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/ddg.13706","article-title":"Increase of scabies in Germany and development of resistant mites? Evidence and consequences","volume":"17","author":"Sunderkotter","year":"2019","journal-title":"J Dtsch Dermatol Ges"},{"issue":"5","key":"10.1016\/j.tmaid.2023.102585_bib13","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.jaad.2019.01.004","article-title":"Efficacy and safety of antiscabietic agents: a systematic review and network meta-analysis of randomized controlled trials","volume":"80","author":"Thadanipon","year":"2019","journal-title":"J Am Acad Dermatol"}],"container-title":["Travel Medicine and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893923000455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893923000455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:09:23Z","timestamp":1761487763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1477893923000455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":13,"alternative-id":["S1477893923000455"],"URL":"https:\/\/doi.org\/10.1016\/j.tmaid.2023.102585","relation":{},"ISSN":["1477-8939"],"issn-type":[{"value":"1477-8939","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u201cOne-shot\u201d combined therapy with oral ivermectin and local benzyl benzoate: is the current best therapeutic option in the era of permethrin resistant scabies?","name":"articletitle","label":"Article Title"},{"value":"Travel Medicine and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmaid.2023.102585","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102585"}}